Goldman Sachs Group Inc Pep Gen Inc. Transaction History
Goldman Sachs Group Inc
- $596 Billion
- Q1 2025
A detailed history of Goldman Sachs Group Inc transactions in Pep Gen Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 40,240 shares of PEPG stock, worth $56,336. This represents 0.0% of its overall portfolio holdings.
Number of Shares
40,240
Previous 40,240
-0.0%
Holding current value
$56,336
Previous $56,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding PEPG
# of Institutions
72Shares Held
25MCall Options Held
19.6KPut Options Held
80.8K-
Ra Capital Management, L.P. Boston, MA10.7MShares$15 Million0.31% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct2.68MShares$3.75 Million0.01% of portfolio
-
Suvretta Capital Management, LLC New York, NY1.66MShares$2.33 Million0.1% of portfolio
-
Viking Global Investors LP1.48MShares$2.08 Million0.01% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA1.35MShares$1.89 Million0.0% of portfolio
About PepGen Inc.
- Ticker PEPG
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 23,631,900
- Market Cap $33.1M
- Description
- PepGen Inc., a clinical-stage biotechnology company, focuses on the development of oligonucleotide therapeutics for use in the treatment of severe neuromuscular and neurologic diseases. The company's lead product candidate is PGN-EDO51, an EDO peptide in Phase I clinical trials to treat individuals with Duchenne muscular dystrophy (DMD). It is a...